Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 117 | 1 | 2 | 16 | 6 |
| Cost of Goods | 0 | 0 | 139 | 30 | 73 |
| Gross Profit | 117 | 1 | -137 | -14 | -67 |
| Operating Expenses | 977 | 2,840 | 514 | 2,171 | 2,200 |
| Operating Income | -860 | -2,838 | -512 | -2,155 | -2,194 |
| Interest Expense | 207 | 182 | -76 | 1,219 | 115 |
| Other Income | -91 | 92 | -90 | 4 | 75 |
| Pre-tax Income | -1,158 | -2,928 | -525 | -3,369 | -2,234 |
| Income Tax | -111 | N/A | 175 | -1 | 82 |
| Net Income Continuous | -1,047 | -2,928 | -700 | -3,368 | -2,315 |
| Minority Interests | -105 | -94 | -317 | -51 | -52 |
| Net Income | $-942 | $-2,834 | $-383 | $-3,318 | $-2,264 |
| EPS Basic Total Ops | -0.08 | -0.29 | 0.25 | -0.82 | -0.68 |
| EPS Basic Continuous Ops | -0.09 | -0.30 | 0.19 | -0.83 | -0.70 |
| EPS Diluted Total Ops | -0.08 | -0.29 | 0.25 | -0.82 | -0.68 |
| EPS Diluted Continuous Ops | -0.09 | -0.30 | 0.19 | -0.83 | -0.70 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.40 | -0.35 | N/A | N/A |
| EBITDA(a) | $-746 | $-2,736 | $-152 | $-2,147 | $-2,187 |